OrthoPediatrics (2X7) Financial Statements
OrthoPediatrics Financial Overview
OrthoPediatrics's market cap is currently $721.72M. The company's EPS TTM is $-1.43; its P/E ratio is -21.59; OrthoPediatrics is estimated to report earnings on March 10, 2027, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 236.35M | $ 204.73M | $ 148.73M | $ 122.29M | $ 98.05M |
| Gross Profit | $ 172.66M | $ 148.60M | $ 111.25M | $ 90.66M | $ 73.40M |
| Operating Income | $ -29.00M | $ -29.52M | $ -26.75M | $ -25.40M | $ -18.02M |
| EBITDA | $ -12.07M | $ -20.23M | $ -8.38M | $ -8.69M | $ -7.19M |
| Net Income | $ -39.65M | $ -37.82M | $ -20.97M | $ 1.26M | $ -16.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 60.85M | $ 68.83M | $ 80.31M | $ 118.29M | $ 54.91M |
| Total Assets | $ 508.63M | $ 473.21M | $ 438.75M | $ 427.73M | $ 308.40M |
| Total Debt | $ 99.99M | $ 80.90M | $ 10.06M | $ 907.00K | $ 28.51M |
| Net Debt | $ 80.43M | $ 37.08M | $ -21.00M | $ -8.08M | $ 19.50M |
| Total Liabilities | $ 162.03M | $ 118.64M | $ 61.72M | $ 49.08M | $ 83.03M |
| Stockholders' Equity | $ 346.60M | $ 354.57M | $ 377.02M | $ 378.65M | $ 225.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.96M | $ -41.31M | $ -46.03M | $ -31.80M | $ -29.07M |
| Operating Cash Flow | $ -4.85M | $ -27.05M | $ -27.05M | $ -21.77M | $ -13.06M |
| Investing Cash Flow | $ -43.63M | $ -13.16M | $ 41.68M | $ -113.37M | $ -7.41M |
| Financing Cash Flow | $ 23.98M | $ 53.13M | $ 7.30M | $ 135.97M | $ 6.00K |
Currency in USD
